1298451 | OSTEAR17_H | Osteoarthritis QTL 17 (human) | 2.4 | 0.0004 | Joint/bone inflammation | osteoarthritis | 11 | 1 | 25188105 | Human |
597382107 | GWAS1478181_H | monocyte count QTL GWAS1478181 (human) | | 1e-18 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 1 | 9181780 | 9181781 | Human |
597358683 | GWAS1454757_H | monocyte percentage of leukocytes QTL GWAS1454757 (human) | | 8e-14 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 1 | 9181780 | 9181781 | Human |
597381434 | GWAS1477508_H | monocyte percentage of leukocytes QTL GWAS1477508 (human) | | 1e-26 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 1 | 9181780 | 9181781 | Human |
597588985 | GWAS1645845_H | monocyte count QTL GWAS1645845 (human) | | 5e-16 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 1 | 9181780 | 9181781 | Human |
597415250 | GWAS1511324_H | lymphocyte:monocyte ratio QTL GWAS1511324 (human) | | 5e-08 | leukocyte quantity (VT:0000217) | | 1 | 9181780 | 9181781 | Human |
597592500 | GWAS1649360_H | high density lipoprotein cholesterol measurement QTL GWAS1649360 (human) | | 8e-12 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 1 | 9181780 | 9181781 | Human |
1298463 | BP9_H | Blood pressure QTL 9 (human) | 3.9 | | Blood pressure | hypertension susceptibility | 1 | 1 | 25188105 | Human |
1643380 | BW316_H | Body weight QTL 316 (human) | 2.62 | 0.0002 | Body weight | BMI | 1 | 7585503 | 33585503 | Human |
597601808 | GWAS1658668_H | monocyte count QTL GWAS1658668 (human) | | 2e-15 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 1 | 9181780 | 9181781 | Human |
1576329 | MYI9_H | Myocardial infarction susceptibility QTL 9 (human) | 12 | | Myocardial infarction susceptibility | early-onset | 1 | 7585503 | 33585503 | Human |
597359535 | GWAS1455609_H | granulocyte percentage of myeloid white cells QTL GWAS1455609 (human) | | 7e-13 | granulocyte quantity (VT:0000334) | | 1 | 9181780 | 9181781 | Human |
597608296 | GWAS1665156_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1665156 (human) | | 3e-11 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 1 | 9181780 | 9181781 | Human |
597602950 | GWAS1659810_H | monocyte count QTL GWAS1659810 (human) | | 3e-30 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 1 | 9181780 | 9181781 | Human |
597602788 | GWAS1659648_H | monocyte count QTL GWAS1659648 (human) | | 1e-17 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 1 | 9181780 | 9181781 | Human |
597409537 | GWAS1505611_H | aspartate aminotransferase measurement QTL GWAS1505611 (human) | | 5e-15 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 1 | 9181780 | 9181781 | Human |
597452071 | GWAS1548145_H | aspartate aminotransferase measurement QTL GWAS1548145 (human) | | 1e-13 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 1 | 9181780 | 9181781 | Human |
1576325 | MYI1_H | Myocardial infarction susceptibility QTL 1 (human) | 11.68 | 1e-12 | Myocardial infarction susceptibility | early-onset | 1 | 7585503 | 33585503 | Human |